ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

AGFX Argentex Group Plc

29.30
0.20 (0.69%)
12 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Argentex Group Plc LSE:AGFX London Ordinary Share GB00BJLPH056 ORD �0.0001
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.20 0.69% 29.30 29.10 30.80 30.00 30.00 30.00 179,860 16:35:11
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Security,commodity Exchanges 49.9M 5.1M 0.0423 7.09 35.04M
Argentex Group Plc is listed in the Security,commodity Exchanges sector of the London Stock Exchange with ticker AGFX. The last closing price for Argentex was 29.10p. Over the last year, Argentex shares have traded in a share price range of 26.00p to 95.00p.

Argentex currently has 120,429,055 shares in issue. The market capitalisation of Argentex is £35.04 million. Argentex has a price to earnings ratio (PE ratio) of 7.09.

Argentex Share Discussion Threads

Showing 2051 to 2073 of 2375 messages
Chat Pages: Latest  83  82  81  80  79  78  77  76  75  74  73  72  Older
DateSubjectAuthorDiscuss
14/7/2023
10:49
He has a video on Stockopedia (yesterday)where he says he sold out of Argentex to rebalance his portfolio.
trident5
14/7/2023
10:13
I have no idea (nor do I care) if Paul Hill held/sold. If I did I would ask him directly and request he post here. I suggest you do the same.
toffeeman
14/7/2023
09:31
Yes you have had your say so be a good chap and don’t show your spiteful side by trying to deramp to justify your decision. If you feel you can find a company that has consistent growth throughout the years (please let me know of one, just one) then move on to it.
big7ime
14/7/2023
08:49
I see Paul Hill sold out after the interview as well.

2022 £m
Q1 9.5
Q2 10.0
Q3 17.4
Q4 13.6
Total 50.5

2023
Q1 12.3
Q2 12.7
H1 25.0

You are forgetting that Q3 last year was anomalous due to the Truss mini-budget. I suspect they could be £5m down on that this year. Time will tell.

topvest
14/7/2023
07:22
Yeah, the market is massive and they’ve been growing as fast as they dare, he seems very confident that the margins will be better too
Still very early stage in their growth path so am happy to ride out any short term turbulence,

big7ime
14/7/2023
07:15
Harry Adams says staff numbers have double over the last 2 1/2 years not over the past year, so not such a spike in staff overhead, plus not all new feet under the table.
Staff number in November were 137 and they are now 170.
H2 last year revenue was £30m, so to do £55m full year, H2 revenue would need to be flat.
To do £35m requires 16.7% revenue growth in H2 on last year which isn't unreasonable.
Cash position in December was £26.2m, equivalent to 23.1p a share.
Recent trading update should have had more detail, especially in the current economic environment.

eagle eye
14/7/2023
07:08
Lmao the size of these posters trades yesterday. Haha what small time pirrocks
shstt1
13/7/2023
22:22
The flip side of course is any £1 overshoot in revenue would add £1 in net profit.

When did you buy in Trident? Your posting history is almost entirely negative here.

I continue to hold most of my original holding, though not as big as it was last year.

dr biotech
13/7/2023
20:20
Potentially very positive gearing of profits to revenue is why I’m here, but the problem is working out whether the current/prospective ratings are reflecting the current lack of it at the moment. Certainly better than being on a rating of 30 in expectation.
yump
13/7/2023
20:11
Gross margins are nearly 100% and so revenue shortfalls massively impact the bottom line. I didn't like Harry's body language in the video. I think he knows H2 is a tall order and current trading is sluggish. The cost base is massively expanded, so if they don't hit £35m in H2 it will almost be a 1:1 reduction in net profits for every £ of shortfall. Of course, Q3 will likely be slow as well as its summer, so it will all be down to Q4 which will probably need to be c£20m. That's a big ask.
topvest
13/7/2023
18:41
Quite, the sole focus on revenue is disconcerting.
trident5
13/7/2023
17:22
The important measure is surely time since the hires vs the time to get up to speed. On IPO, most employees were mature in terms of sales relationships.

That leaves the rating and whether its worth waiting for the overall market to improve with money in something else that has yet to prove its expansion plans are working.

I have no doubt that there is now a big extra “overhead̶1; here of employee costs.

Its very difficult to figure if that represents potential or not.

Unfortunately, AGFX quote revenue all the time, as do 90% of all floated businesses. While there’s enough revenue to pay salaries, why rock the revenue boat ?

If they’re not quoting profit, is that deliberate, complacent or incompetent ?

yump
13/7/2023
13:47
There's being patient, and then there's bag holding. It's been years since the IPO.
manics
13/7/2023
09:02
Their explanation is that new hires take time to reach their peak earnings.

Important to be patient, although this has been a slow burner.

doctor888
13/7/2023
08:43
Likewise, I've just exited at a small loss for just the reasons you've mentioned.
trident5
13/7/2023
07:21
Well I have reluctantly sold for a 10% loss before dividends. Its been on my amber list for a while and I should have sold before the trading update. Anyway, listending to Harry confirmed my worst fears:
hxxps://www.voxmarkets.co.uk/media/64ad740b14590db399c5c6d0/?context=/series/q-and-a
Argentex are not really delivering and I don't trust them. Points to note:
1. RNS says in line, but Harry clearly says broadly in line and we know what that means!
2. Harry mentions they have 170 staff or double last year's average.
To me this looks a bit like Utilitywise and we know how that ended. Basically, they are employing more and more sales staff, but they are less productive than the key early better staff. It's still a cold calling sweatshop despite the technology.
I think the risk of a profit warning is very high now unless they have a stellar H2. I think the likely sales outturn is closer to £55m rather than £60m which would halve the profit number particularly as they are up against strong prior year comparatives in H2. Basically, they are making less money than they did post-IPO on far fewer staff.
The other thing that I don't like is the LLP profit skim which is about £5m a year.
Anyway, pleased to be out, albeit I definitely should have cut earlier as its not worked out versus the original thesis. Good luck to thse that remain.

topvest
12/7/2023
16:50
direc buying here any comments!
Argentex Group PLC



("Company" or the "Group")



Director / PDMR Dealing



Argentex Group PLC, the service led, tech enabled provider of currency management and payment services to international institutions and corporates, announces that Lee McDarby, Chief Commercial Officer, on 10 July 2023 purchased 16,500 ordinary shares of £0.0001 each ("Ordinary Shares") in the Company at a price of 120 pence per Ordinary Share.



Following this transaction, Lee McDarby's total beneficial interest in the Group is 16,500 Ordinary Shares representing approximately 0.01% of the Group's issued share capital.

ali47fish
12/7/2023
11:04
Thanks for the video - it gave me confidence that they can see opportunity ahead!

Digby isn't Digital !?

chinahere
12/7/2023
05:55
In this fascinating interview, CEO Harry Adams of Argentex, takes me through yesterday's 'in line' trading update, alongside explaining what was behind #AGFX's impressive 28% YoY jump in H1’23 sales to £25m.
brummy_git
10/7/2023
18:54
Agreed that this was a mildly disappointing update - Q1 was already a tad pedestrian and Q2 also, versus weak comparatives. Still growing, but not firing on all cylinders. Q3 and Q4 are normally stronger. £60m looks more of a stretch now. I suppose the downside is if they only achieve £30m or so in H2 leading to £55m revenue, but they seem to be comfortable in hitting £60m at this stage, with the H2 weighting. I still hold.

The change of Chair seems logical given age and tenure. He will continue to serve for another 2 months. The new Chair seems strong.

Anyway, any slight disappointment gets hammered in these markets. Even an out-perfrom only gets a very modest share price increase!

topvest
10/7/2023
15:45
No mention of margins or cash position which is disappointing in a market devoid of confidence.
H1 revenue of £25m (+28% H1 22) leaves £35m for the second half to December.
Revenue split between H1/H2 last year was 38.6%/61.4%.
Based on Singer's £60m revenue forecast this year, Argentex has done 41.66% first half which is a tad ahead of expectations.
News the online platform and the new alternative transaction banking product exceeded expectations is a plus.
New offices in Holland and Australia should help boost topline growth in H2.
Singer EPS forecasts for FY to Dec 23 and Dec 24 are 9.1p and 11.8p respectively, which leaves the 12 month rolling forward PER of x 11 (116p/10.45p = 11).
Good value, but what isn't in this market.

eagle eye
10/7/2023
12:16
I reckon it's due to the overall AIM market being depressed and investors market outlook currently. Doesn't look as an expensive stock and the in line is based on previous upgraded guidance. I reckon when overall investor outlook improves this will be a big winner. I am holding onto mine.
thebeast1
10/7/2023
11:58
thanks taurus- i am not buying either but why in line gest hit like this!
ali47fish
Chat Pages: Latest  83  82  81  80  79  78  77  76  75  74  73  72  Older

Your Recent History

Delayed Upgrade Clock